| 期刊簡介 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | BIOPHARM INTERNATIONAL LetPub Score 5.1
50 ratings
Rate
Reputation 6.2 Influence 3.4 Speed 9.4 | ||||||||||||||||||||
| 期刊簡稱 | BIOPHARM INT | ||||||||||||||||||||
| ISSN | 1542-166X | ||||||||||||||||||||
| E-ISSN | 1939-1862 | ||||||||||||||||||||
| h-index | 25 | ||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||
| 自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||
| 官方網站 | http://www.biopharminternational.com/ | ||||||||||||||||||||
| 在線稿件提交 | |||||||||||||||||||||
| 開放訪問 | No | ||||||||||||||||||||
| 出版商 | Advanstar Communications Inc. | ||||||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||||||
| 出版國/地區 | UNITED STATES | ||||||||||||||||||||
| 發行頻率 | 月刊 | ||||||||||||||||||||
| 創刊年 | 2002 | ||||||||||||||||||||
| 每年文章數 | 21每年文章數趨勢 | ||||||||||||||||||||
| 黃金OA百分比 | 0.00% | ||||||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q4
| ||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1542-166X%5BISSN%5D | ||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||||||
| 競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||
|
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [BIOPHARM INTERNATIONAL] 的評論 | 撰寫評論 |
| 作者: rama.pande11@gmail.com 領域: 医药科学 審稿時間: 1.0 month(s) 結果: 直接被接受 撰寫評論 |
2019-02-03 10:33:52 評論於 1. Dr. A.P. Mishra apmishrasagar@gmail.com Department of Chemistry Dr. H. S. Gour Central University, Sagar, India Govil Girijesh govil@tifr.res.in Tata Institute of Fundamental Research, Mumbai Dr. Govil is expertised in the field of bio-membrane studies. H.A. Meshram meshram@iict.res.in CSIR-Indian institute of Chemical Technology, Telangana Dr. Meshram is expertise in assessing the biological properties of drug.  (0) 讚！ | rama.pande11@gmail.com  |
| 作者: rama.pande11@gmail.com 領域: 医药科学 審稿時間: 1.0 month(s) 結果: 直接被接受 撰寫評論 |
2019-02-03 10:33:52 評論於 1. Dr. A.P. Mishra apmishrasagar@gmail.com Department of Chemistry Dr. H. S. Gour Central University, Sagar, India Govil Girijesh govil@tifr.res.in Tata Institute of Fundamental Research, Mumbai Dr. Govil is expertised in the field of bio-membrane studies. H.A. Meshram meshram@iict.res.in CSIR-Indian institute of Chemical Technology, Telangana Dr. Meshram is expertise in assessing the biological properties of drug. (0) 讚！ | rama.pande11@gmail.com |
| 作者: rama.pande11@gmail.com 領域: 医药科学 審稿時間: 1.0 month(s) 結果: 直接被接受 撰寫評論 |
2019-02-03 10:33:51 評論於 Most of the editors and reviewers are experts in the field of bio-membrane studies or in assessing the biological properties of drugs. I recommend this journal to anyone conducting research in this field. (0) 讚！ | rama.pande11@gmail.com |
| 作者: Ogelsvie 領域: 医学 審稿時間: 2.0 month(s) 結果: 待定＆不明 撰寫評論 |
2018-11-20 17:59:46 評論於 . The lower score is better. (0) 讚！ | Ogelsvie |
| 作者: 平原梓云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2018-11-20 11:25:22 評論於 The lower one is relatively better (0) 讚！ | 平原梓云 |
| 作者: 元德酱大魔王 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2018-08-28 23:16:06 評論於 Has anyone submitted to this magazine before? (0) 讚！ | 元德酱大魔王 |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2017-07-14 15:26:23 評論於 As long as we can secure journals from SCI sources, it's enough. If the school starts using CiteScore for calculations, there's no need to worry. On one hand, CiteScore includes a wider range of journals, so this journal is surely included. Additionally, it benefits smaller journals, leveling the playing field for everyone. I hope the school adopts CiteScore (0) 讚！ | 凌霄高洁 |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us
